Catherine C. Turkel serves as Executive at Novus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Catherine C. Turkel has executed 10 insider transactions totaling $303.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 12, 2024 involved purchasing 1,600 shares valued at $5.0K.
Catherine C. Turkel currently holds 3,100 shares of Novus Therapeutics, Inc. (NVUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catherine C. Turkel has been a net buyer of NVUS stock. They have purchased $284.7K and sold $18.6K worth of shares.
Catherine C. Turkel's most recent insider trade was on Aug 12, 2024, when they purchased 1,600 shares at $3.13 per share.
Get notified when new Form 4 filings are submitted
| $2.84 |
| Discretionary |
| May 21, 2019 | NVUS | $3.7K | Sale | 1,914 | $1.91 | Discretionary |
| May 20, 2019 | NVUS | $14.9K | Sale | 7,623 | $1.96 | Discretionary |
| Mar 14, 2019 | NVUS | $0 | Award | 20,000 | $N/A | Discretionary |
| Sep 12, 2018 | NVUS | $83.5K | Purchase | 16,632 | $5.02 | Discretionary |
| Sep 11, 2018 | NVUS | $77.7K | Purchase | 17,048 | $4.56 | Discretionary |
| Sep 5, 2018 | NVUS | $3.2K | Purchase | 805 | $3.97 | Discretionary |
| Mar 13, 2018 | NVUS | $0 | Award | 20,000 | $N/A | Discretionary |
| May 10, 2017 | NVUS | $111.0K | Purchase | 11,111 | $9.99 | Discretionary |